Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed from cells' surface and circulate in soluble form (sTACI). We investigated the impact of serum BLyS and sTACI levels at diagnosis in CLL p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyrtsonis, Marie-Christine, Sarris, Katerina, Koulieris, Efstathios, Maltezas, Dimitrios, Nikolaou, Eftychia, Angelopoulou, Maria K., Bartzis, Vassiliki, Tzenou, Tatiana, Dimou, Maria, Siakandaris, Mariana P., Viniou, Nora A., Sachanas, Sotirios, Kalpadakis, Christina, Sfikakis, Petros P., Pangalis, Gerassimos A., Panayiotidis, Panayiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138780/
https://www.ncbi.nlm.nih.gov/pubmed/25162001
http://dx.doi.org/10.1155/2014/159632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138780/
https://www.ncbi.nlm.nih.gov/pubmed/25162001
http://dx.doi.org/10.1155/2014/159632

Ejemplares similares